Paul Kasian

Operates as a bank holding company with interest in providing national banking services

Engages in affinity DNA, easy DNA and gene type testing activities

Operates as a biotechnology research and development company that manufactures anti-viral drugs

Functions as a College/University

Provides investment advice services

WAM has a bottom-up market approach and has an active management style. The firm tries to identify stocks available at a reasonable price, which promise above-average growth and strong future shareholder value.^Their approach is based on fundamental analysis of individual companies, analysis which relies on company publications and statutory reports, trade and business journals, stockbroker research, and direct contact with company management.^WAM also uses shareholder value analysis (SVA) techniques to calculate returns generated by the business, its cost of capital, and its valuation each year. The firm uses CFROI to identify the relationship between the cash generated by a business relative to the cash invested in it. ^Another SVA technique employed by the firm uses historical actual financial results for past years and the firm's forecasts for future years to calculate a company's value using discounted cashflow methodology WAM's portfolios are fairly concentrated so as to maximize the impact of research and analysis efforts without losing the risk reduction of diversification. The firm further manages risk by limiting exposure to individual stocks or sectors.

Promotes governance and develops leadership skills

Manufactures and markets blood testing vitro diagnostic medical devices

Provides IT and engineering solutions to oil. gas and chemical industries